A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in India and to Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in India (DiabCare India 2011)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01351922

Acronym

DiabCare India

Enrollment

12000

Registered

2011-05-11

Start date

2011-04-30

Completion date

2011-09-30

Last updated

2017-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Asia. The aim of this observational study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in India. Perceptions and practices of physicians and subjects about diabetes management will also be evaluated.

Interventions

OTHERNo treatment given

Patients will fill out a questionaire by interview.

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit * First twenty patients of diabetes visiting the centre during the data collection period * Patients willing to sign the informed consent form

Exclusion criteria

* Repetition of any patient as patients should not be included twice for any reason * Unwilling to participate or unable to comply with protocol requirements

Design outcomes

Primary

Measure	Time frame
Mean age of onset of type 1 diabetes mellitus	Evaluation visit
Mean age of onset of type 2 diabetes mellitus	Evaluation visit
Mean duration of treatment of type 2 diabetes mellitus	Evaluation visit
Percentage of patients on Insulin therapy	Evaluation visit
Percentage of patients on Oral Anti-Diabetics Drug (OADs) therapy	Evaluation visit
Mean duration of diabetes in type 1 patients	Evaluation visit
Mean duration of diabetes in type 2 patients	Evaluation visit
Mean FPG (fasting plasma glucose)	Evaluation visit
PPG (post prandial glucose)	Evaluation visit
HbA1c (Glycosylated Haemoglobin)	Evaluation visit
Percentage of patients archiving HbA1c target below or equal 6.5%	Evaluation visit
Percentage of patients archiving HbA1c target below or equal 7.0%	Evaluation visit
Percentage of patients having complications (dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications)	Evaluation visit

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026